Sickle Cell Disease With Vaso-Occlusive Crisis – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Sickle Cell Disease With Vaso-Occlusive Crisis – Drugs In Development, 2024 report and make more profitable business decisions.
Vaso-occlusive crisis associated with sickle cell disease is a painful episode that occurs in people who have sickle cell anemia. Symptoms include fever, pain, fatigue, abdominal pain and swelling, headaches, shortness of breath, dehydration, and infection. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, blood transfusion, and surgery.
The Sickle Cell Disease With Vaso-Occlusive Crisis drugs in development market research report provide comprehensive information on the therapeutics under development for Sickle Cell Disease With Vaso-Occlusive Crisis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Sickle Cell Disease With Vaso-Occlusive Crisis and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Sickle Cell Disease With Vaso-Occlusive Crisis | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 9 molecules, with 9 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Sickle Cell Disease With Vaso-Occlusive Crisis therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Sickle Cell Disease With Vaso-Occlusive Crisis pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Sickle Cell Disease With Vaso-Occlusive Crisis treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Asklepion Pharmaceuticals LLCChugai Pharmaceutical Co Ltd
F. Hoffmann-La Roche Ltd
Fera Pharmaceuticals LLC
GlycoMimetics Inc
Hartis Pharma SA
Novartis AG
NuvOx Pharma LLC
Pfizer Inc
Prolong Pharmaceuticals LLC
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Sickle Cell Disease With Vaso-Occlusive Crisis reports